ClassID:

96467

C07J1/0074 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane; Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified Esters

Recent Application in this class:
#1
20250319106
2025-10-16

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

#2
20250122236
2025-04-17

INTERMEDIATE FOR PREPARING FULVESTRANT AND PREPARATION METHOD THEREFOR

#3
20240025941
2024-01-25

IMPROVED PROCESS FOR THE PREPARATION OF TRENBOLONE AND/OR TRENBOLONE ACETATE

#4
20230295217
2023-09-21

2-METHOXYESTRADIOL DERIVATIVES AND MEDICAL USES THEREOF

#5
20230227492
2023-07-20

MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME

#6
20220110950
2022-04-14

19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof

#7
20210139531
2021-05-13

19-nor neuroactive steroids and methods of use thereof

#8
20200155576
2020-05-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#9
20200016178
2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#10
20190135853
2019-05-09

6-substituted estradiol derivatives and methods of use

#11
20190112331
2019-04-18

19-nor neuroactive steroids and methods of use thereof

#12
20180311262
2018-11-01

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#13
20180141971
2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#14
20170246191
2017-08-31

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#15
20160108080
2016-04-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

#16
20160060288
2016-03-03

Ester derivatives of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-estra-1,3,5(10)-triene-3,17beta-diol having anticancer activity and preparation method thereof

#17
20140315874
2014-10-23

6-substituted demethyl-estradiol derivatives as selective ER-β agonists

#18
20130225845
2013-08-29

PROCESS FOR PREPARATION OF ESTRADIOL VALERATE AND A NOVEL CRYSTALLINE FORM A OF ESTRADIOL DIVALERATE

#19
20120071455
2012-03-22

6-SUBSTITUTED DEMETHYL-ESTRADIOL DERIVATIVES AS SELECTIVE ER-BETA AGONISTS

#20
20110195942
2011-08-11

Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

#21
20100130463
2010-05-27

6-substituted estradiol derivatives and methods of use

#22
20100105934
2010-04-29

FULVESTRANT INTERMEDIATE

#23
20090318721
2009-12-24

Process for the preparation of 7alpha-alkylated 19-norsteroids

#24
20090306417
2009-12-10

Process for the preparation of 7alpha-alkylated 19-norsteroids

#25
20090023695
2009-01-22

METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE

#26
20080182829
2008-07-31

8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens

#27
20080167283
2008-07-10

Nandrolone 17β-carbonates

#28
20080039643
2008-02-14

Process for the preparation of phenolic hydroxy-substituted compounds

#29
20060286064
2006-12-21

Therapeutic polymers and methods

#30
20060030552
2006-02-09

Process for the preparation of 7α-alkylated 19-norsteroids

#31
20050153949
2005-07-14

Testosterone derivative

#32
20050143366
2005-06-30

Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders

#33
20050130944
2005-06-16

Method of making and using 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate

#34
20050075322
2005-04-07

Androgenic 7-substituted 11-halogen steroids